These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 9657560

  • 21. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
    Leff JA, Busse WW, Pearlman D, Bronsky EA, Kemp J, Hendeles L, Dockhorn R, Kundu S, Zhang J, Seidenberg BC, Reiss TF.
    N Engl J Med; 1998 Jul 16; 339(3):147-52. PubMed ID: 9664090
    [Abstract] [Full Text] [Related]

  • 22. Effects of oral montelukast on airway function in acute asthma.
    Cýllý A, Kara A, Ozdemir T, Oğüş C, Gülkesen KH.
    Respir Med; 2003 May 16; 97(5):533-6. PubMed ID: 12735671
    [Abstract] [Full Text] [Related]

  • 23. Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma.
    Bateman ED, Goehring UM, Richard F, Watz H.
    J Allergy Clin Immunol; 2016 Jul 16; 138(1):142-149.e8. PubMed ID: 26915674
    [Abstract] [Full Text] [Related]

  • 24. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial.
    Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening AP, Haahtela T, Holgate ST, Picado C, Menten J, Dass SB, Leff JA, Polos PG.
    BMJ; 2003 Oct 18; 327(7420):891. PubMed ID: 14563743
    [Abstract] [Full Text] [Related]

  • 25. The efficacy and tolerability of intravenous montelukast in acute asthma exacerbations in Japanese patients.
    Adachi M, Taniguchi H, Tohda Y, Sano Y, Ishine T, Smugar SS, Hisada S.
    J Asthma; 2012 Aug 18; 49(6):649-56. PubMed ID: 22742205
    [Abstract] [Full Text] [Related]

  • 26. Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma.
    Price DB, Hernandez D, Magyar P, Fiterman J, Beeh KM, James IG, Konstantopoulos S, Rojas R, van Noord JA, Pons M, Gilles L, Leff JA, Clinical Outcomes with Montelukast as a Partner Agent to Corticosteroid Therapy (COMPACT) International Study Group.
    Thorax; 2003 Mar 18; 58(3):211-6. PubMed ID: 12612295
    [Abstract] [Full Text] [Related]

  • 27. A randomized, placebo-controlled study of intravenous montelukast in children with acute asthma.
    Morris CR, Becker AB, Piñieiro A, Massaad R, Green SA, Smugar SS, Gurner DM.
    Ann Allergy Asthma Immunol; 2010 Feb 18; 104(2):161-71. PubMed ID: 20306820
    [Abstract] [Full Text] [Related]

  • 28. [Single dose of montelukast as an effective prevention of post exercise bronchospasm in children with bronchial asthma].
    Gaszczyk G, Latoś T, Słowikowski A, Janiak B.
    Med Wieku Rozwoj; 2004 Feb 18; 8(3 Pt 2):847-56. PubMed ID: 15858257
    [Abstract] [Full Text] [Related]

  • 29. Oral montelukast in acute asthma exacerbations: a randomised, double-blind, placebo-controlled trial.
    Ramsay CF, Pearson D, Mildenhall S, Wilson AM.
    Thorax; 2011 Jan 18; 66(1):7-11. PubMed ID: 20956393
    [Abstract] [Full Text] [Related]

  • 30. A randomized study comparing the effect of loratadine added to montelukast with montelukast, loratadine, and beclomethasone monotherapies in patients with chronic asthma.
    Lu S, Liu N, Dass SB, Reiss TF.
    J Asthma; 2009 Jun 18; 46(5):465-9. PubMed ID: 19544166
    [Abstract] [Full Text] [Related]

  • 31. Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial.
    Pizzichini E, Leff JA, Reiss TF, Hendeles L, Boulet LP, Wei LX, Efthimiadis AE, Zhang J, Hargreave FE.
    Eur Respir J; 1999 Jul 18; 14(1):12-8. PubMed ID: 10489822
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma.
    Diamant Z, Grootendorst DC, Veselic-Charvat M, Timmers MC, De Smet M, Leff JA, Seidenberg BC, Zwinderman AH, Peszek I, Sterk PJ.
    Clin Exp Allergy; 1999 Jan 18; 29(1):42-51. PubMed ID: 10051701
    [Abstract] [Full Text] [Related]

  • 34. Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma.
    Barnes NC, Pujet JC.
    Thorax; 1997 Jun 18; 52(6):523-7. PubMed ID: 9227718
    [Abstract] [Full Text] [Related]

  • 35. The efficacy of montelukast during the allergy season in pediatric patients with persistent asthma and seasonal aeroallergen sensitivity.
    Papadopoulos NG, Philip G, Giezek H, Watkins M, Smugar SS, Polos PG.
    J Asthma; 2009 May 18; 46(4):413-20. PubMed ID: 19484680
    [Abstract] [Full Text] [Related]

  • 36. Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma.
    Kanniess F, Richter K, Janicki S, Schleiss MB, Jörres RA, Magnussen H.
    Eur Respir J; 2002 Nov 18; 20(5):1080-7. PubMed ID: 12449158
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Airway mechanics after withdrawal of a leukotriene receptor antagonist in children with mild persistent asthma: Double-blind, randomized, cross-over study.
    Kim JH, Lee S, Shin YH, Ha EK, Lee SW, Kim MA, Yoon JW, Baek HS, Choi SH, Han MY.
    Pediatr Pulmonol; 2020 Dec 18; 55(12):3279-3286. PubMed ID: 32965787
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.